Cetera Investment Advisers
ONC

Cetera Investment Advisers’s BeOne Medicines Ltd ONC Stock Holding History

Cetera Investment Advisers’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$626K Sell
2,198
-173
-7% -$51K ﹤0.01% 3487
2026
Q1 		$704K Sell
2,371
-377
-14% -$122K ﹤0.01% 3215
2025
Q4 		$835K Buy
2,748
+860
+46% +$281K ﹤0.01% 2987
2025
Q3 		$643K Buy
1,888
+10
+0.5% +$3.04K ﹤0.01% 3177
2025
Q2 		$455K Buy
1,878
+106
+6% +$26K ﹤0.01% 3041
2025
Q1 		$482K Sell
1,772
-119
-6% -$27.8K ﹤0.01% 2872
2024
Q4 		$349K Buy
1,891
+103
+6% +$21K ﹤0.01% 2983
2024
Q3 		$401K Sell
1,788
-469
-21% -$84.4K ﹤0.01% 2839
2024
Q2 		$322K Sell
2,257
-66
-3% -$10.2K ﹤0.01% 2971
2024
Q1 		$363K Buy
+2,323
New +$374K ﹤0.01% 2868

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Cetera Investment Advisers's ONC Position: Q2 2026 in Review

Cetera Investment Advisers reduced its BeOne Medicines Ltd (ONC) stake by 7.3% in Q2 2026, selling an estimated $51K and leaving 2,198 shares worth $626K. The position accounts for ﹤0.01% of the portfolio, ranked #3487.

Cetera Investment Advisers first reported a position in ONC in Q1 2024 and has held it in 10 quarters since. The position peaked at $835K in Q4 2025. 283 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Cetera Investment Advisers held 2,198 shares of BeOne Medicines Ltd worth $626K as of Q2 2026.
  • Cetera Investment Advisers sold 173 BeOne Medicines Ltd shares in Q2 2026, an estimated $51K.
  • BeOne Medicines Ltd made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #3487 holding.
  • Cetera Investment Advisers first reported a position in BeOne Medicines Ltd in Q1 2024 and has held it in 10 quarters since.
  • Cetera Investment Advisers's BeOne Medicines Ltd position peaked at $835K in Q4 2025.
  • 283 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.